PunjiPUNJI
Pharmaceuticals & BiotechnologySmall Cap

Granules India Ltd.

GRANULES · ISIN: INE101D01020

Granules India Ltd. is a small cap company in the Pharmaceuticals & Biotechnology sector, listed on the NSE under ISIN INE101D01020.

Price and day-range figures above come from the latest NSE/BSE close, not a delayed quote. Where shown, RSI (14-day), SMA50/SMA200, and ADX measure momentum and trend from real daily closing prices - an RSI above 70 or below 30 typically signals overbought or oversold conditions, and a price above its SMA200 is a common long-term uptrend marker. ADTV (20-day average daily traded value) reflects real liquidity, not a projection. Fundamentals, when available, come from the company's own filed financials rather than a third-party estimate.

Constituent of NIFTY 500 TRI (0.07%), NIFTY SC 250 TRI (0.57%)

Close (as of 2026-10-29)
₹837.35
-0.37% today
Day Range
₹820 - ₹842.85
Market Cap (Small Cap)
₹22,841.22 Cr
Quality Score (as of 2026-06-30)
63.6/100

Price History

CHART

Granules India Ltd. - growth of ₹100

Growth of ₹100 invested on 2026-05-08, not raw price - the standard way to compare performance regardless of price level. Daily resolution for the last 90 days, weekly up to 2 years, monthly beyond that.

-122460971332026-05-082026-07-172026-08-122026-08-262026-09-092026-09-242026-10-092026-10-262026-10-29

1M

-1.09%

3M

+1.54%

6M

+19.67%

1Y

+48.32%

3Y CAGR

+36.96%

5Y CAGR

-

Earnings (TTM)

LEARN: Revenue and PAT · EPS · P/E

CHART

Granules India Ltd. - revenue & profit (TTM)

Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.

0 Cr1577 Cr3154 Cr4731 Cr6308 CrQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Revenue (TTM)PAT (TTM)

17.62%

EBITDA Margin (TTM)

Technicals

843.11

SMA (50)

737.49

SMA (200)

47.99%

1Y Return

56.5255

Avg Traded Value (20D, ₹Cr)

As of 2026-10-29.

Shareholding Pattern

CHART

Shareholding by category

As of 2026-06-30.

37.39%62.61%TOP 2100%
Promoter 37.39%Public 62.61%

F&O Sentiment

Nearest expiry: 2025-08-28 · As of 2025-08-28.

0.5935

PCR (OI)

460

Max Pain Strike

Corporate Actions

No corporate actions on record for this stock.

Recent Deals

DateTypeQuantity
2026-10-13SHORT_SELL1
2026-10-08SHORT_SELL1
2026-09-15SHORT_SELL25
2026-09-11BULK39,04,871
2026-09-11BLOCK4,58,452
2026-09-11BLOCK3,12,796
2026-09-11BLOCK72,360
2026-09-11BLOCK4,16,692
2026-09-11BULK13,18,051
2026-09-11BLOCK34,74,080
2026-09-11BLOCK5,73,065
2026-09-11BLOCK2,86,535
2026-09-11BLOCK6,87,679
2026-09-11BLOCK3,20,926
2026-09-11BLOCK3,00,000
2026-09-11BLOCK2,86,535
2026-09-11BLOCK1,32,95,129
2026-09-11BLOCK91,594
2026-09-11BLOCK11,54,316
2026-09-11BLOCK5,73,065

Frequently asked questions

What is Granules India Ltd.'s 1-year and 3-year return?

Granules India Ltd.'s 1-year price return is +48.32%. Its 3-year CAGR (annualized return) is +36.96%. Both are price-only returns (no dividends added back), computed from the nearest available trading day to each anniversary - not a forecast of future performance.

What is Granules India Ltd.'s latest financial performance?

Granules India Ltd.'s trailing-twelve-month (TTM) revenue as of 2026-06-30 is ₹5,632 Cr, with a TTM profit after tax of ₹662 Cr and an EBITDA margin of 17.62%. TTM figures sum the most recent four reported quarters rather than a single quarter, which smooths out seasonal swings in a business's revenue and profit. EPS (earnings per share) over this TTM window is ₹27.06, with a 5-year EPS growth rate of 5.54% - a rough proxy for how consistently the company has grown per-share earnings over a full market cycle.

What is Granules India Ltd.'s quality score?

Granules India Ltd. has a Punji quality score of 63.6 out of 100 as of 2026-06-30. This composite score is computed from the company's reported fundamentals (profitability, balance-sheet strength, and consistency of earnings, among other factors) and is designed to be comparable across companies in different sectors. A higher score indicates a fundamentally stronger business by these measures, though it isn't a price target or a buy/sell signal - a high-quality company can still be expensively priced, and a lower-scoring one can still be a reasonable investment at the right valuation.

What do Granules India Ltd.'s technical indicators show?

As of 2026-10-29, Granules India Ltd.'s RSI (14-day) is 52.28 - readings above 70 typically signal an overbought stock, below 30 an oversold one, so this reading sits in neutral territory. Its 50-day moving average is currently above its 200-day moving average, a "golden cross" setup when the shorter average is above (often read as a bullish medium-term signal) or a "death cross" when below (often read as bearish). These are backward-looking statistical measures, not predictions of future price movement.

Who are the major shareholders of Granules India Ltd.?

As of 2026-06-30, Granules India Ltd.'s shareholding is split across Promoter (37.39%), Public (62.61%). Promoter holding of 37.39% indicates the founders/controlling group's own stake in the company - a higher promoter holding is often read as a sign of management's confidence in the business, though it should be considered alongside pledge status and recent buying/selling activity, which this figure alone doesn't capture.

Is Granules India Ltd. part of any major market index?

Yes - Granules India Ltd. is a constituent of NIFTY 500 TRI (0.07% weight) and NIFTY SC 250 TRI (0.57% weight). Index membership means the stock is automatically bought by every index fund and ETF tracking that benchmark, in proportion to its weight, which brings a baseline level of passive-fund demand independent of active investor sentiment. A stock's weight in an index is typically determined by its free-float market capitalization relative to the index's other constituents, and is periodically rebalanced as relative market caps shift.

What does the F&O market show for Granules India Ltd.?

As of 2025-08-28 (nearest expiry 2025-08-28), Granules India Ltd.'s put-call ratio by open interest is 0.5935 - below 1, typically read as bullish positioning (more open interest on calls than puts). The max pain strike is ₹460, the price at which option writers as a group would owe the least to option buyers at expiry - a reference level some traders watch, not a price target. F&O positioning reflects derivatives-market sentiment over a specific expiry window, not a fundamental view on the company.

Has Granules India Ltd. seen any recent bulk or block deals?

Yes, as of 2026-10-13 - the most recent recorded deal was a SHORT_SELL on 2026-10-13 for 1 shares. Bulk and block deals are large trades (above exchange-defined thresholds) that must be publicly disclosed, and are often watched as a signal of institutional or high-net-worth investor conviction - though a single deal doesn't establish a trend, and the counterparty's reasons for buying or selling aren't disclosed alongside the trade itself.

Stock data · Not financial advice · Past performance does not indicate future returns